β-Hydroxybutyrate Exerts Anti-Tumor Effects in Nasopharyngeal Carcinoma Through Caspase-3-Mediated Apoptosis
ENT Discovery · 2026
DOI: 10.15302/entd.2026.090004 ↗Kurz gefasst
Fachartikel in der Zeitschrift ENT Discovery, 2026. Verfasst von Zihui Rong und 8 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben.
Abstract (Originalsprache)
Background
Ketogenic enzymes are downregulated and act as tumor suppressors in nasopharyngeal carcinoma (NPC), yet the antitumor mechanisms of the ketone body β-hydroxybutyrate (β-HB) in NPC remain unclear.
Methods
Network pharmacology, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment, and molecular docking were used to identify candidate β-HB–NPC targets. In vitro, the effects of β-HB on cell viability, colony formation, caspase-3 enzymatic activity, and apoptosis were assessed in NPC cells. Dose- and time-response cell viability analyses were also performed using NP69 cells. Caspase-3 involvement was evaluated using Z-DEVD-FMK and CASP3 siRNA. Two independent NPC C17 patient-derived xenograft (PDX) experiments used alternate-day fasting or a ketogenic diet to induce ketosis. Epstein–Barr virus (EBV) lytic-gene expression, EBV DNA copy number, and tumor EBV-encoded RNAs (EBER) status were also assessed.
Results
We identified 177 overlapping β-HB–NPC targets and five hub targets, with caspase-3 prioritized as an apoptosis-associated functional node. Molecular docking predicted a compatible binding pose for β-HB within caspase-3, but did not establish direct binding. In vitro, β-HB suppressed cell viability and clonogenic growth without reducing NP69 viability under the tested conditions. It increased caspase-3 activity, cleaved caspase-3, PARP-1, and promoted apoptosis. Both Z-DEVD-FMK and CASP3 silencing attenuated β-HB-induced apoptosis. In vivo, both independent PDX experiments demonstrated tumor suppression accompanied by elevated ketone-related measures. Tumors from both intervention groups exhibited reduced Ki-67 expression, and increased terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) positivity. β-HB also upregulated the EBV immediate-early lytic gene expression (BZLF1 and BRLF1), while a nonsignificant trend toward increased EBER positivity was observed in fasting-treated tumors.Conclusion: β-HB suppresses NPC cell growth and promotes apoptosis, with caspase-3 serving as a functional mediator. In vivo, both dietary interventions suppressed tumor growth and were accompanied by increases in ketone-related measures. β-HB also induces EBV immediate-early lytic gene expression, supporting further investigation of ketone metabolism as a potential therapeutic strategy for NPC.
Zitieren
APA
Rong, Z., Wei, W., Tang, S., Lu, Y., Zhou, X., Xiao, X., Liang, J., Zhao, W., & Zhang, Z. (2026). β-Hydroxybutyrate Exerts Anti-Tumor Effects in Nasopharyngeal Carcinoma Through Caspase-3-Mediated Apoptosis. ENT Discovery. https://doi.org/10.15302/entd.2026.090004
Vancouver
Rong Z, Wei W, Tang S, Lu Y, Zhou X, Xiao X, et al. β-Hydroxybutyrate Exerts Anti-Tumor Effects in Nasopharyngeal Carcinoma Through Caspase-3-Mediated Apoptosis. ENT Discovery. 2026. doi:10.15302/entd.2026.090004
BibTeX
@article{Rong2026,
author = {Rong, Zihui and Wei, Wanqi and Tang, Shiyue and Lu, Yunliang and Zhou, Xiaoying and Xiao, Xue and Liang, Jinfeng and Zhao, Weilin and Zhang, Zhe},
title = {β-Hydroxybutyrate Exerts Anti-Tumor Effects in Nasopharyngeal Carcinoma Through Caspase-3-Mediated Apoptosis},
journal = {ENT Discovery},
year = {2026},
doi = {10.15302/entd.2026.090004}
}
EUVIMED